Q-omics provides the consensus-scored RNVU1-33 profile across patient tissues and cancer cell-line models. RNVU1-33 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in CHOL. Additionally, RNVU1-33 RNA expression shows 7,178 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight CHOL, and GBM as cancer lineages where RNVU1-33 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.